Progression of tractional retinal detachment following intravitreal bevacizumab

Acta Ophthalmologica

Volumn 87, Issue 5, 2009, Pages 571-572

  Jonas, Jost B ^a   Schmidbauer, Matthias ^a   Rensch, Florian ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

ADULT; CASE REPORT; DIABETIC RETINOPATHY; DISEASE COURSE; FEMALE; HUMAN; INTRAOCULAR PRESSURE; LASER COAGULATION; LETTER; OPHTHALMOSCOPY; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA NEOVASCULARIZATION; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 70350498941     PISSN: 1755375X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2008.01225.x     Document Type: Letter

References (17)

1. ®) in patients with severe proliferative diabetic retinopathy. Br J Ophthalmol 92 : 213 216.
2. Chilov MN, Grigg JR Playfair TJ (2007 Bevacizumab (Avastin) for the treatment of neovascular glaucoma. Clin Exp Ophthalmol 35 : 494 496.
3. Dell'omo R, Kulkarni A Franks WA (2007 Intravitreal and intracameral bevacizumab to treat neovascular complications of retinopathy of prematurity. Acta Ophthalmol Scand 2007 Dec 12; [Epub ahead of print].
4. Grisanti S, Biester S, Peters S, Tatar O, Ziemssen F, Bartz-Schmidt KU Tuebingen Bevacizumab Study Group (2006 Intracameral bevacizumab for iris rubeosis. Am J Ophthalmol 142 : 158 160.
5. Iliev ME, Domig D, Wolf-Schnurrbusch U, Wolf S Sarra GM (2006 Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma. Am J Ophthalmol 142 : 1054 1056.
6. Jonas JB, Libondi T, von Baltz S Vossmerbaeumer U (2007 Intravitreal bevacizumab for vitreous haemorrhage. Acta Ophthalmol Scand 2007 Dec 12; [Epub ahead of print].
7. ®) with pars plana vitrectomy. Acta Ophthalmol Scand 2007 Dec 18; [Epub ahead of print].
8. Mason JO III., Albert MA Jr., Mays A Vail R (2006 Regression of neovascular iris vessels by intravitreal injection of bevacizumab. Retina 26 : 839 841.
9. Michels S, Rosenfeld PJ, Puliafito CA, Michels S, Marcus EN, Lenchus JD Venkatraman AS (2005 Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study. Ophthalmology 112 : 1035 1047.
10. ®) in proliferative diabetic retinopathy. Acta Ophthalmol Scand 2007 Nov 7; [Epub ahead of print].
11. Rosenfeld PJ, Moshfeghi AA Puliafito CA (2005 Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 36 : 331 335.
12. Ruiz-Moreno JM, Montero JA, Lugo F, Amat P Staicu C (2008 Intravitreal bevacizumab in recurrent diabetic vitreous haemorrhage after vitrectomy. Acta Ophthalmol 86 : 231 232.
13. Shima C, Sakaguchi H, Gomi F et al. (2008 Complications in patients after intravitreal injection of bevacizumab. Acta Ophthalmol 86 : 372 376.
14. Silva Paula J, Jorge R, Alves Costa R, Rodrigues Mde L Scott IU (2006 Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma. Acta Ophthalmol Scand 84 : 556 557.
15. Soliman W, Vinten M, Sander B, Soliman KA, Yehya S, Rahman MS Larsen M (2008 Optical coherence tomography and vessel diameter changes after intravitreal bevacizumab in diabetic macular oedema. Acta Ophthalmol 86 : 365 371.
16. Tonello M, Costa RA, Almeida FP, Barbosa JC, Scott IU Jorge R (2008 Panretinal photocoagulation versus PRP plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy (IBeHi study). Acta Ophthalmol 86 : 385 389.
17. Yazdani S, Hendi K Pakravan M (2007 Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma. J Glaucoma 16 : 437 439.